Clinical Trials Logo

Cinobufacin Injection clinical trials

View clinical trials related to Cinobufacin Injection.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01236690 Recruiting - Hepatoma Clinical Trials

Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy

Start date: November 2010
Phase: Phase 2
Study type: Interventional

Cinobufacini has the effects of anticancer, improving the liver function, elevation of immunity and little side effects, and is important and significant for the patients with hepatitis, liver cirrhosis and hepatomas. Compared with transarterial chemoembolization (TACE) , the clinical effect of cinobufacini is non-inferior/ equivalent.Compared with TACE, cinobufacini is superior in security .